StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Regeneron Pharmaceuticals, Inc.
NasdaqGS:REGN
Sector
Location
Market Cap
USD 57.75 B
Share Price
USD 534.91
Avg Daily Volume
1,314,125
Change (1 day)
1.89%
Change (1 year)
-49.40%
Change (YTD)
-24.91%
Regeneron Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 130.79
Regeneron Pharmaceuticals, Inc. Revenue Per Share is USD 130.79 for the Trailing 12 Months (TTM) ending March 31, 2025, a 6.75% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Regeneron Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 122.52, a 9.17% change year over year.
-
Regeneron Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 112.22, a -23.36% change year over year.
-
Regeneron Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 146.43, a 80.89% change year over year.
-
Regeneron Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 80.95, a 16.18% change year over year.
Competitors
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
Cencora, Inc.
USD 295.33
COR
-4.52
-1.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%
Haleon plc
USD 5.16
HLN.L
+0.02
0.40%
Daiichi Sankyo Company, Limited
USD 23.01
4568.T
-0.14
-0.59%
UCB SA
USD 196.98
UCB.BR
+0.20
0.10%
Hansoh Pharmaceutical Group Company Limited
USD 3.82
3692.HK
+0.03
0.87%
Teva Pharmaceutical Industries Limited
USD 16.73
TEVA.TA
-0.12
-0.70%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
Cencora, Inc.
USD 295.33
COR
-4.52
-1.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%
Haleon plc
USD 5.16
HLN.L
+0.02
0.40%
Daiichi Sankyo Company, Limited
USD 23.01
4568.T
-0.14
-0.59%
UCB SA
USD 196.98
UCB.BR
+0.20
0.10%
Hansoh Pharmaceutical Group Company Limited
USD 3.82
3692.HK
+0.03
0.87%
Teva Pharmaceutical Industries Limited
USD 16.73
TEVA.TA
-0.12
-0.70%